# TRANEXAMIC ACID

NDC: 43066-008
Generic name: tranexamic acid
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200701

FDA application: ANDA212360

## Active ingredients

- TRANEXAMIC ACID: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-008"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-008
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32750a05-6617-46e8-b9e7-04e613e6bf4b